Log In
BCIQ
Print this Print this
 

trastuzumab (BCD-022)

  Manage Alerts
Collapse Summary General Information
Company Biocad CJSC
Description 
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase III
Standard IndicationBreast cancer
Indication DetailsTreat HER2 positive metastatic breast cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today